China’s Clinical Trials Face New Regulatory Challenges
In China, the landscape for clinical trials has shifted significantly due to new government regulations.…
Newswire
PharmatrophiX and Circular Partner on Neurodegenerative Drugs
PharmatrophiX and Circular Genomics have partnered to advance blood-based circular RNA biomarkers in neurodegenerative drug…
CDMO Partnerships Evolve in Biopharma
David Enloe, CEO of Rose BioSolutions, argues that the traditional outsourcing model in biopharma is…
Lonza Expands U.S. CDMO Network with Merck KGaA Acquisition
Lonza plans to significantly expand its U.S. contract development and manufacturing organization (CDMO) footprint by…
Multiomic Atlas Reveals Predictable Patterns in Glioblastoma Cells
New research from the Wellcome Sanger Institute and collaborators reveals that aggressive glioblastoma (GB) brain…
Bernie Sanders to Influence FDA Funding Bill
Democrats’ recent electoral victory may significantly affect negotiations regarding the funding for the Food and…
FDA Workshop on Bioequivalence for Topical Generic Drugs
This half-day virtual workshop features FDA expert presentations and audience Q&A on bioequivalence (BE) approaches…
FDA Highlights Treatment Options for Opioid Use Disorder
The FDA has provided information regarding treatment options and therapies aimed at addressing opioid use…
Sanofi Halts Development of Nurix-Partnered Immune Drug
Sanofi has decided to stop the development of its immune drug partnered with Nurix. This…
MSD’s Non-Oncology Sales Expected to Double
MSD’s expanding non-oncology portfolio is expected to play an increasingly important role in cushioning the…